Braxia Scientific (TSE:BRAX) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Braxia Scientific Corp. has announced the successful election of its board of directors and the approval of a major asset sale at its recent Annual General and Special Meeting. The company, known for its innovative ketamine treatments for depression, is moving forward with the sale of its assets including the Canadian Rapid Treatment Center of Excellence. This move is part of Braxia’s proposed transaction aimed at enhancing its commitment to mental health treatments.
For further insights into TSE:BRAX stock, check out TipRanks’ Stock Analysis page.